Literature DB >> 25110213

Effect of angiotensin II infusion on rhythmic clock gene expression and local renin-angiotensin system in the aorta of Wistar rats.

I Herichova, K Zsoldosova, A Vesela, M Zeman.   

Abstract

OBJECTIVE: Endogenous daily rhythms in physiology are regulated by the circadian system consisting of the central and peripheral components. The renin-angiotensin system, involved predominantly in water balance and blood pressure control, exerts 24 h rhythmicity in many of its parameters. The present study is aimed to study possible interactions between these two control systems. We analyzed effects induced by angiotensin II administration on clock gene expression in the aorta of rat and an ability of angiotensin II to influence the local tissue renin-angiotensin system.
METHODS: Angiotensin II was infused in a dose of 100 ng/kg/min by subcutaneously implanted osmotic minipumps for 28 days to male Wistar rats. Gene expression was measured by real time PCR.
RESULTS: Angiotensin II administration resulted in an increase in blood pressure, heart weight/body weight index, and water intake in comparison with controls. We observed a significant phase advance in per2 and npas2 mRNA rhythms and decreased mesor of npas2 rhythmic expression in the aorta of angiotensin II-treated rats compared to control. Angiotensin II administration did not influence daily pattern and level of at1 mRNA expression. The ratio ace/ace2 showed a rhythmic pattern in the aorta of control rats with peak levels in the dark period.
CONCLUSIONS: Angiotensin II infusion influenced clock gene expression and diminished a daily rhythm in ace/ace2 mRNA ratio indicating modulatory effect of angiotensin II on tissue renin-angiotensin system in the aorta.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25110213     DOI: 10.4149/endo_2014_03_144

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  7 in total

Review 1.  An overview of the emerging interface between cardiac metabolism, redox biology and the circadian clock.

Authors:  Rodrigo A Peliciari-Garcia; Victor Darley-Usmar; Martin E Young
Journal:  Free Radic Biol Med       Date:  2018-02-10       Impact factor: 7.376

Review 2.  Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression.

Authors:  J Zlacká; K Stebelová; M Zeman; I Herichová
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

3.  Effect of 17β-estradiol on the daily pattern of ACE2, ADAM17, TMPRSS2 and estradiol receptor transcription in the lungs and colon of male rats.

Authors:  Iveta Herichová; Soňa Jendrisková; Paulína Pidíková; Lucia Kršková; Lucia Olexová; Martina Morová; Katarína Stebelová; Peter Štefánik
Journal:  PLoS One       Date:  2022-06-28       Impact factor: 3.752

4.  Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection.

Authors:  Miguel Meira E Cruz; Masaaki Miyazawa; David Gozal
Journal:  Eur Respir J       Date:  2020-06-04       Impact factor: 16.671

5.  Does Angiotensin II Peak in Response to SARS-CoV-2?

Authors:  Léder Leal Xavier; Paula Fernanda Ribas Neves; Lisiê Valeria Paz; Laura Tartari Neves; Pamela Brambilla Bagatini; Luís Fernando Saraiva Macedo Timmers; Alberto Antônio Rasia-Filho; Régis Gemerasca Mestriner; Andrea Wieck
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

6.  Ace2 and Tmprss2 Expressions Are Regulated by Dhx32 and Influence the Gastrointestinal Symptoms Caused by SARS-CoV-2.

Authors:  Fuyi Xu; Jun Gao; Buyan-Ochir Orgil; Akhilesh Kumar Bajpai; Qingqing Gu; Enkhsaikhan Purevjav; Athena S Davenport; Kui Li; Jeffrey A Towbin; Dennis D Black; Joseph F Pierre; Lu Lu
Journal:  J Pers Med       Date:  2021-11-16

7.  Potential protective effect against SARS-CoV-2 infection by APOE rs7412 polymorphism.

Authors:  Isabel Espinosa-Salinas; Gonzalo Colmenarejo; Cristina M Fernández-Díaz; Marta Gómez de Cedrón; J Alfredo Martinez; Guillermo Reglero; Ana Ramírez de Molina
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.